- Home
- EDIT vs VEEA Comparison
EDIT vs VEEA Comparison
Compare EDIT & VEEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- VEEA
- Stock Information
- Founded
- EDIT 2013
- VEEA 2014
- Country
- EDIT United States
- VEEA United States
- Employees
- EDIT N/A
- VEEA N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- VEEA
- Sector
- EDIT Health Care
- VEEA
- Exchange
- EDIT Nasdaq
- VEEA NYSE
- Market Cap
- EDIT 108.1M
- VEEA 112.2M
- IPO Year
- EDIT 2016
- VEEA N/A
- Fundamental
- Price
- EDIT $1.25
- VEEA $1.56
- Analyst Decision
- EDIT Buy
- VEEA
- Analyst Count
- EDIT 14
- VEEA 0
- Target Price
- EDIT $8.08
- VEEA N/A
- AVG Volume (30 Days)
- EDIT 2.5M
- VEEA 22.6K
- Earning Date
- EDIT 03-05-2025
- VEEA 05-23-2025
- Dividend Yield
- EDIT N/A
- VEEA N/A
- EPS Growth
- EDIT N/A
- VEEA N/A
- EPS
- EDIT N/A
- VEEA N/A
- Revenue
- EDIT $32,314,000.00
- VEEA $140,035.00
- Revenue This Year
- EDIT N/A
- VEEA N/A
- Revenue Next Year
- EDIT N/A
- VEEA N/A
- P/E Ratio
- EDIT N/A
- VEEA N/A
- Revenue Growth
- EDIT N/A
- VEEA N/A
- 52 Week Low
- EDIT $1.12
- VEEA $1.33
- 52 Week High
- EDIT $7.41
- VEEA $18.56
- Technical
- Relative Strength Index (RSI)
- EDIT 41.70
- VEEA N/A
- Support Level
- EDIT $1.24
- VEEA N/A
- Resistance Level
- EDIT $1.32
- VEEA N/A
- Average True Range (ATR)
- EDIT 0.11
- VEEA 0.00
- MACD
- EDIT -0.03
- VEEA 0.00
- Stochastic Oscillator
- EDIT 2.94
- VEEA 0.00
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About VEEA VEEA INC
Veea Inc is a company providing edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. It has first-in-class VeeaHub smart computing hubs integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.